Related Experiment Video
Updated: Jun 7, 2026
12:19
Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle
Published on: June 7, 2024
Innate immunity and cancer therapy.
Kouji Maruyama1, Zohair Selmani, Hidee Ishii
1Experimental Animal Facility, Shizuoka Cancer Center Research Institute, 1007 Shimonagakubo, Sunto-gun, Nagaizumi-cho, Shizuoka 411-8777, Japan. k.maruyama@scchr.jp
International Immunopharmacology
|October 20, 2010
Summary
Toll-like receptors (TLRs) are crucial in cancer immunotherapy, bridging innate immunity and antitumor responses. However, TLRs also support tumor growth, presenting a dual role that necessitates careful consideration for targeted drug development.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- Classical cancer immunotherapy leverages microbial components to elicit immune responses against tumors.
- Toll-like receptors (TLRs), key sensors of microbial components, illuminate the innate immune system's role in recognizing antigens and mediating antitumor effects.
- Emerging evidence highlights TLRs' function in tissue homeostasis, a role exploited by tumors to promote their survival and growth, indicating TLR signaling is a double-edged sword in cancer therapy.
Purpose of the Study:
- To review the dual role of Toll-like receptors (TLRs) in cancer immunology.
- To discuss the implications of TLR signaling in cancer therapy.
- To explore the potential of TLR-targeting drugs for innate immunity-based cancer treatments.
Main Methods:
- Literature review of studies on Toll-like receptors (TLRs) in cancer.
- Analysis of the role of innate immunity in cancer therapy.
- Examination of TLR-targeting drugs and their mechanisms.
Main Results:
- Toll-like receptors (TLRs) play a significant role in both anti-tumor immunity and tumor progression.
- Tumor cells can utilize TLR signaling pathways to create a microenvironment conducive to their survival.
- TLR signaling represents a complex target in cancer therapy due to its multifaceted functions.
Conclusions:
- Innate immunity-based cancer therapy, particularly targeting Toll-like receptors (TLRs), holds promise.
- Understanding the dual role of TLRs is critical for developing effective cancer treatments.
- TLR-targeting drugs represent a potential therapeutic strategy for harnessing innate immunity against cancer.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:21Introduction to Innate and Adaptive Immunity
The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...